Risk: Benefit Profile of Sodium-Glucose Cotransporter 2 Inhibitors: JCEM Dr Kartikeya Kohli17 May 2021 11:30 AM ISTSodium-glucose cotransporter 2 inhibitors (SGLT2i) are first-line antidiabetic agents with demonstrated cardiovascular benefits. In a recent...
Use of corticosteroid Eluting Stents may increase infection risk after sinus surgery MD Bureau19 April 2021 6:15 AM ISTImplantation of sinus stents and spacers can be used as adjuvant management to maintain patency of sinuses after endoscopic sinus surgery for chronic...
No info to CDSCO about specific severe adverse event linked to Covid-19 vaccines: MoS Health Medical Dialogues Bureau6 Feb 2021 5:31 PM IST"If any vaccine recipient develops symptoms of COVID19, vaccine recipient will be provided a medically recognized standard of care in the government...
Covid-19: Over 20 lakh Healthcare Workers Vaccinated on 11th day of inoculation drive Medical Dialogues Bureau28 Jan 2021 9:00 AM IST6 AEFIs were reported till 7 pm on the eleventh day of the Covid-19 vaccination drive.
Covid-19: Over 15 lakh Healthcare Workers Vaccinated, 123 adverse events reported so far Medical Dialogues Bureau25 Jan 2021 9:00 AM ISTTotal 11 persons have been hospitalized so far. 0.0007% people have recorded hospitalization against vaccinations.
Clinical trial participants paid over Rs 12 crore compensation in last 3 years for adverse events: DCGI Ruchika Sharma6 Dec 2020 11:00 AM ISTAddressing a webinar, ''Regulatory Pathways for COVID19 Vaccines, Clinical trials, Rolling Reviews and Adverse Event Monitoring'', Drugs Controller...
Even short course of Oral steroids tied to severe adverse events: Study Dr.Niharika Harsha B13 July 2020 8:25 AM ISTA recent study in Taiwan found that the short course of oral corticosteroids called 'oral corticosteroid bursts' caused severe adverse events. The...
Low-dose methotrexate linked to increased adverse events in some Dr. Kamal Kant Kohli18 Feb 2020 4:56 PM ISTUSA: Methotrexate is the most commonly used drug for systemic rheumatic diseases worldwide and the recommended first-line agent for rheumatoid...
